Abstract
Background & Aims
Existing evidence suggests that long-term exposure to ambient fine particulate pollution (PM2.5) may increase metabolic dysfunction-associated fatty liver disease (MAFLD) risk. However, there is still limited evidence on the association of PM2.5 constituents with MAFLD. Therefore, this study explores the associations between the five main chemical constituents of PM2.5 and MAFLD to provide more explicit information on the liver exposome.
Methods
A total of 76,727 participants derived from the China Multi-Ethnic Cohort, a large-scale epidemic survey in southwest China, were included in this study. Multiple linear regression models were used to estimate the pollutant-specific association with MAFLD. Weighted quantile sum regression was used to evaluate the joint effect of the pollutant-mixture on MAFLD and identify which constituents contribute most to it.
Results
Three-year exposure to PM2.5 constituents was associated with a higher MAFLD risk and more severe liver fibrosis. Odds ratios for MAFLD were 1.480, 1.426, 1.294, 1.561, 1.618, and 1.368 per standard deviation increase in PM2.5, black carbon, organic matter, ammonium, sulfate, and nitrate, respectively. Joint exposure to the five major chemical constituents was also positively associated with MAFLD (odds ratio 1.490, 95% CI 1.360–1.632). Nitrate contributed most to the joint effect of the pollutant-mixture. Further stratified analyses indicate that males, current smokers, and individuals with a high-fat diet might be more susceptible to ambient PM2.5 exposure than others.
Conclusions
Long-term exposure to PM2.5 and its five major chemical constituents may increase the risk of MAFLD. Nitrate might contribute most to MAFLD, which may provide new clues for liver health. Males, current smokers, and participants with high-fat diets were more susceptible to these associations.
Impact and implications
This large-scale epidemiologic study explored the associations between constituents of fine particulate pollution (PM2.5) and metabolic dysfunction-associated fatty liver disease (MAFLD), and further revealed which constituents play a more important role in increasing the risk of MAFLD. In contrast to previous studies that examined the effects of PM2.5 as a whole substance, this study carefully explored the health effects of the individual constituents of PM2.5. These findings could (1) help researchers to identify the specific particles responsible for hepatotoxicity, and (2) indicate possible directions for policymakers to efficiently control ambient air pollution, such as targeting the sources of nitrate pollution.
Keywords: Metabolic dysfunction-related fatty liver disease, ambient fine particulate matter constituents, hepatotoxicity, joint exposure analysis
Graphical abstract
Highlights
-
•
Ambient PM2.5 constituents are positively associated with the risk of MAFLD.
-
•
Nitrate is the most heavily weighted particle in the joint effect on MAFLD.
-
•
Smoking and male sex may exacerbate the toxic effects of PM2.5.
-
•
We provide novel insights into the hepatotoxicity of ambient PM2.5.
Introduction
Metabolic dysfunction-associated fatty liver disease (MAFLD) is estimated to exist in about 40% of adults worldwide.[1], [2], [3] There is no curative treatment for MAFLD, so the search for modifiable risk and protective factors remains a clinical and public health priority.3,4
Emerging epidemiologic evidence consistently showed that ambient air pollution may be a risk factor for MAFLD.[5], [6], [7] Specifically, particulate matter 2.5 μm or less in diameter (PM2.5) can reach the pulmonary alveoli, enter the blood circulation, and finally reach the liver, where it is catabolized. Toxicologic studies found that PM2.5 can cause damage to the liver and also lead to metabolic dysfunction in the liver.8,9 These new findings may provide further clues to guide the prevention and clinical treatment of MAFLD.10
Notably, ambient PM2.5 originates from the complex interaction of multiple emissions and chemical reactions; it is a mixture of various chemical constituents, such as elemental carbon, organic carbon, sulfate (SO42−), nitrate (NO3−), and ammonium (NH4+). These PM2.5 constituents have different toxicological profiles, which may lead to different effects on liver health; simultaneously, they can further reflect specific emission sources to inform mitigation strategies. Therefore, understanding the constituent-specific effect on liver health may provide a clearer perspective on PM2.5 hepatotoxicity, which will help establish a more specific source-oriented PM2.5 control strategy. A few studies investigated the effect of chemical constituents of PM2.5 on metabolic disorders or diseases.[11], [12], [13], [14] For instance, black carbon and organic matter were found to be mainly associated with glucose levels,12 particle sulfate mainly associated with metabolic syndrome (MetS),13 and organic carbon matter mainly associated with subclinical atherosclerosis.14 However, evidence on the associations between PM2.5 constituents and MAFLD is limited.
This epidemiologic study aims to assess whether long-term exposure to ambient PM2.5 and five major constituents were associated with the odds of MAFLD and to explore the constituents that contribute most to the joint effect on MAFLD. This study was conducted on the basis of the China Multi-Ethnic Cohort (CMEC), a large-scale cohort composed of several ethnic groups in southwest China.15
Materials and methods
Study design and data collection
We used baseline data from the China Multi-Ethnic Cohort (CMEC) to conduct a cross-sectional, observational study to assess the relationship between PM2.5 constituents and MAFLD. The CMEC recruited 99,556 participants, aged 30-79, from the general population in five southwestern provinces of China between May 2018 and September 2019.15 Participants answered a questionnaire through a face-to-face interview, had physical measurements taken, and provided biological samples. The entire process was guided by uniformly trained investigators and qualified physicians. The study design, survey methods, quality control strategies, and limitations of CMEC have been reported elsewhere.15,16 The CMEC received ethical approval (K2016038 and K2020022) from the Sichuan University Medical Ethical Review Board, and all participants provided written informed consent.
Assessment of PM2.5 and its constituents
Estimates of the monthly total mass of PM2.5 and its five major constituents (black carbon [BC], organic matter [OM], sulfate, nitrate, and ammonium) were obtained from the V4.CH.02 product developed by the Dalhousie University Atmospheric Composition Analysis Group.17 The V4.CH.02 product methodology for datasets used in this study was described before. Briefly, the monthly total mass of PM2.5 at 10 km × 10 km resolution was simulated by the Goddard Earth Observing System chemical transport model, which incorporated the aerosol optical depth retrievals from several satellite instruments and then calibrated with ground-based observations from China meteo-rological monitoring stations.17 Further, concentrations of five major PM2.5 chemical constituents were estimated through simulated relative contributions of each constituent against the total mass of PM2.5.
For this study, the total mass of PM2.5 and the annual concentrations of its five chemical constituents’ before the baseline survey of each CMEC participant was estimated according to the geocoded residential address information. In line with existing studies, we used a 3-year average of total mass PM2.5 and its five chemical constituents before the baseline survey as the individual exposures.
Ascertainment of MAFLD cases
According to the definition for MAFLD proposed by an international expert consensus statement, participants were identified as MAFLD cases if they had hepatic steatosis and met at least one of the following three criteria: overweight or obese, type 2 diabetes mellitus (T2DM) or if they were normal weight with evidence of metabolic dysregulation.18 Hepatic steatosis was detected by abdominal ultrasonography. The presence of overweight or obesity was assessed as body mass index (BMI) ≥23 kg/m2 (Asian-specific cut-off), where BMI was calculated as weight (kg) divided by height squared (m2). T2DM was identified as fasting plasma glucose ≥7.0 mmol/L or hemoglobin A1c ≥6.5%. The presence of metabolic dysregulation was assessed as the presence of two or more of the following conditions: 1) a waist circumference ≥90/80 cm in men/women (the cut-off for Asians), 2) blood pressure ≥130/85 mmHg or related drug treatment, 3) triglycerides ≥1.70 mmol/L or related drug treatment, 4) HDL-C <1.0 mmol/L for males and <1.3 mmol/L for females, 5) prediabetes (i.e., fasting glucose levels from 5.6 to 6.9 mmol/L or hemoglobin A1c from 5.7% to 6.4%), 6) homeostasis model assessment of insulin resistance score ≥ 2.5, and 7) plasma high-sensitivity C-reactive protein level >2 mg/L. Considering related variables collected by the CMEC, this study utilized the first five conditions to diagnose patients in the actual diagnosis process based on the accessibility of data.
Potential confounders and model adjustments
Potential confounders were recognized based on known and suspected MAFLD risk factors associated with PM2.5 exposure and were summarized in a causal-directed acyclic graph (Fig. S1). Potential confounders included individual demographic, socioeconomic, health behavior variables, and environmental factors. Based on the directed acyclic graph, we adjusted our model for age, sex, highest education level attained, annual household income, ethnicity and admission sites, urban area, smoking status, alcohol consumption, unhealthy diets, physical activity, second-hand smoking exposure, biomass fuel exposure, 3-year average temperature, and 3-year average relative humidity. Detailed definitions of these variables are provided in the supplementary text.
Statistical analysis
We used pollutant-specific logistic regression models to estimate the associations between each PM2.5 constituent and MAFLD and calculated the prevalence odds ratio of MAFLD per standard deviation (SD) increase in pollutant concentration to measure the associations. We initially explored the crude association between PM2.5 constituents and MAFLD (model 0), then adjusted for baseline factors (age, sex, education level, household income, ethnicity and admission sites, and urban area) in model 1, and further adjusted for health behaviors (smoking status, alcohol consumption, unhealthy diet, physical activity, second-hand smoking exposure, and biomass fuel exposure) and environmental factors (3-year average temperature and 3-year average relative humidity) in model 2.
We applied a generalized weighted quantile sum (WQS) regression with a logit link function to estimate the association between the PM2.5 constituent mixture and MAFLD.19 The WQS approach simultaneously estimated the weights of each constituent and the coefficient of the PM2.5 mixture. The weights reflected the contribution of each constituent to the association and were used to calculate the weighted sum of constituents, often called the WQS index. The coefficient represents the log odds ratio (OR) per 1-unit increase in the WQS index. We adjusted for the same confounders as those in the final pollutant-specific logistic regression models. As suggested by an anonymous reviewer, we also performed a sensitivity analysis with additional adjustments for central obesity and diabetes mellitus.
To explore whether potential factors would modify the associations, we conducted subgroup analyses by sex (male and female), age group (categorized as ≥65 vs. <65 years), smoking status (never, current smoker, and previous smoker), alcohol consumption (never, low/moderate, and high), the presence of high-fat diet, the presence of central obesity, and the presence of diabetes mellitus. We carried out sensitivity analyses to test the robustness of the findings to different exposure windows (2- and 4-year average concentration), different target populations (additionally excluding participants with self-reported pregnancy, cancer, or tuberculosis and those in Lhasa, Tibet because of low variability of ambient air pollutant owing to high altitude – approximately 3,650 m) and alternative model adjustment (further adjusted for family history of hypertension and diabetes). To evaluate the effects of PM2.5 and its constituents on the severity of MAFLD, we fitted generalized linear regression models with the same confounders as in model 2 in the context of the degree of liver fibrosis and the degree of metabolic disorders, respectively. The degree of liver fibrosis was evaluated by non-invasive test indices (i.e., APRI [aspartate aminotransferase-to-platelet ratio], FIB-4 [fibrosis-4], and Forns index); the severity of metabolic disorders was assessed according to the number of major metabolic disorders (0 to 6). Detailed definitions were described in the supplementary text.
Further, the observations with missing data were excluded if the missing ratio was less than 5% or imputed by the multivariate imputation method if the missing ratio was between 5% and 10%. The results from model 2 with imputed data were compared with the complete case analyses in the supplementary file.
All analyses were performed on complete case data using R version 4.1.0. This study has been reported per the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guideline and the corresponding checklist is shown in Table S1.20
Results
We included 80,201 participants from the CMEC who had the same fixed available address for more than 3 years and for whom MAFLD had been reliably diagnosed or ruled out. Of these, 4.29% of the eligible population were excluded (31 with cirrhosis and 3,443 with data missing on key covariates and potential mod-ifiers), leaving 76,727 participants for analysis. The general characteristics of the participants for analysis are shown in Table 1. Of the 76,727 participants used for analysis, 46,296 (60%) were women; the mean (SD) age was 51.97 (11.53) years. There were 15,216 (19.8%) cases of MAFLD, of which 12,767 (83.9%) had central obesity and 3,689 (24.2%) had diabetes. The distributions of PM2.5 and its constituents are shown in Fig. 1. Based on the participants’ residential addresses, the mean (SD) 3-year concentrations of PM2.5, BC, ammonium, nitrate, OM, and sulfate were 36.39 (21.79), 1.88 (1.14), 5.75 (3.52), 7.23 (5.66), 8.20 (5.05) and 9.78 (5.10) μg/m3, respectively.
Table 1.
Characteristics of the participants according to the presence of MAFLD.
| Variablea | Overall (N = 76,727) | MAFLD |
|
|---|---|---|---|
| No, n = 61,511 | Yes, n = 15,216 | ||
| Demographics | |||
| Age, years | 51.97±11.53 | 51.79±11.69 | 52.69±10.79 |
| Sex | |||
| Male | 30,431 (39.7%) | 23,292 (37.9%) | 7,139 (46.9%) |
| Female | 46,296 (60.3%) | 38,219 (62.1%) | 8,077 (53.1%) |
| BMI, kg/m2 | 24.10±3.42 | 23.35±3.07 | 27.11±3.06 |
| Waist-to-hip ratio | 0.88±0.07 | 0.87±0.07 | 0.93±0.06 |
| Han ethnicity | 46,212 (60.2%) | 36,368 (59.1%) | 9,844 (64.7%) |
| Urban area | |||
| Urban | 38,478 (50.1%) | 29,662 (48.2%) | 8,816 (57.9%) |
| Rural | 38,249 (49.9%) | 31,849 (51.8%) | 6,400 (42.1%) |
| Education level | |||
| Elementary school or below | 38,816 (50.6%) | 31,472 (51.2%) | 7,344 (48.3%) |
| Middle or high school | 29,315 (38.2%) | 23,269 (37.8%) | 6,046 (39.7%) |
| College or above | 8,596 (11.2%) | 6,770 (11.0%) | 1,826 (12.0%) |
| Annual household income, ¥ | |||
| <2,0000 | 27,255 (35.5%) | 22,303 (36.3%) | 4,952 (32.5%) |
| 2,0000-199,999 | 39,094 (51.0%) | 31,265 (50.8%) | 7,829 (51.5%) |
| ⩾200,000 |
10,378 (13.5%) |
7,943 (12.9%) |
2,435 (16.0%) |
| Lifestyle behaviors | |||
| Smoking Status | |||
| Never smoker | 56,928 (74.2%) | 46,234 (75.2%) | 10,694 (70.3%) |
| Current smoker | 15,896 (20.7%) | 12,374 (20.1%) | 3,522 (23.1%) |
| Previous smoker | 3,903 (5.1%) | 2,903 (4.7%) | 1,000 (6.6%) |
| Second-hand smoking exposure | 38,510 (50.2%) | 30,870 (50.2%) | 7,640 (50.2%) |
| Alcohol consumption | |||
| Never | 43,209 (56.3%) | 35,055 (57.0%) | 8,154 (53.6%) |
| Low or Moderateb | 25,703 (33.5%) | 20,342 (33.1%) | 5,361 (35.2%) |
| Highb | 7,815 (10.2%) | 6,114 (9.9%) | 1,701 (11.2%) |
| Total energy intake, kcal/day | 1,644.38±607.05 | 1,630.78±602.38 | 1,699.32±622.58 |
| High-fat dietc | 42,512 (55.4%) | 33,828 (55.0%) | 8,684 (57.1%) |
| Low fruit or vegetable intaked | 26,992 (35.2%) | 21,612 (35.1%) | 5,380 (35.4%) |
| Physical activity | |||
| Low | 46,453 (60.5%) | 37,784 (61.4%) | 8,669 (57.0%) |
| Moderate | 4,798 (6.3%) | 3,788 (6.2%) | 1,010 (6.6%) |
| High | 25,476 (33.2%) | 19,939 (32.4%) | 5,537 (36.4%) |
| Biomass fuel exposure | |||
| Light | 12,104 (15.8%) | 9,680 (15.7%) | 2,424 (15.9%) |
| Moderate | 60,676 (79.1%) | 48,480 (78.8%) | 12,196 (80.2%) |
| Heavy |
3,947 (5.1%) |
3,351 (5.4%) |
596 (3.9%) |
| Clinical characteristics | |||
| Central obesitye | 44,483 (58.0%) | 31,716 (51.6%) | 12,767 (83.9%) |
| Diabetes mellitus | 8,575 (11.2%) | 4,886 (7.9%) | 3,689 (24.2%) |
| Family history of hypertension | 24,480 (31.9%) | 18,969 (30.8%) | 5,511 (36.2%) |
| Family history of diabetes mellitus | 8,294 (10.8%) | 5,942 (9.7%) | 2,352 (15.5%) |
MAFLD, metabolic dysfunction-associated fatty liver disease; PM2.5, particulate matter 2.5 μm or less in diameter.
Mean ± SD or n (%) were used to present descriptive analysis of the data for continuous and categorical variables, respectively; differences between MAFLD and non-MAFLD participants were examined with t test (for continuous variables) and Chi-squared test (for categorical variables).
Low/moderate alcohol consumption was defined as consuming ≤20 g/day of alcohol for women or ≤30 g/day for men; high alcohol consumption was defined as consuming >20 g/day of alcohol for women or >30 g/day for men.
High-fat diet was defined as consuming fat ≥75 g/day.
Low fruit or vegetable intake was defined daily fruit and vegetable intake <500 g.
Central obesity was defined as a waist-to-hip ratio of 0.85 or higher for women and 0.9 or higher for men.
Fig. 1.
Distribution of the 3-year average concentrations of PM2.5 mass and its major chemical constituents at the residences of CMEC participants.
BC, black carbon; OM, organic matter; PM2.5, particulate matter 2.5 μm or less in diameter.
The pollutant-specific logistic regression models showed that PM2.5 mass and its constituents are both associated with MAFLD (Table 2). Higher concentrations of both PM2.5 and its constituents were associated with a statistically significantly higher prevalence of MAFLD. For the fully adjusted model, a per-SD increase in the 3-year average PM2.5 mass concentration was positively associated with MAFLD (OR 1.480; 95% CI 1.366-1.605), and per-SD increases in the 3-year average BC (1.426, 1.323-1.538), OM (1.294, 1.196-1.401), ammonium (1.561, 1.440-1.692), sulfate (1.618, 1.501-1.744) and nitrate (1.368, 1.262-1.482) concentrations were also positively associated with MAFLD.
Table 2.
Odds ratio (95% CIs) of MAFLD associated with each SD increase in 3-year exposure to PM2.5 and its major chemical constituents.
| Model 0 | Model 1 | Model 2 | |
|---|---|---|---|
| PM2.5 | 1.141 (1.121–1.161) | 1.133 (1.053–1.219) | 1.480 (1.366–1.605) |
| Black carbon | 1.152 (1.132–1.173) | 1.130 (1.055–1.210) | 1.426 (1.323–1.538) |
| Organic matter | 1.135 (1.115–1.155) | 1.018 (0.948–1.093) | 1.294 (1.196–1.401) |
| Ammonium | 1.139 (1.118–1.159) | 1.236 (1.147–1.332) | 1.561 (1.440–1.692) |
| Sulfate | 1.137 (1.116–1.157) | 1.367 (1.272–1.469) | 1.618 (1.501–1.744) |
| Nitrate | 1.138 (1.118–1.158) | 1.059 (0.986–1.139) | 1.368 (1.262–1.482) |
MAFLD, metabolic dysfunction-associated fatty liver disease; PM2.5, particulate matter 2.5 μm or less in diameter; SD, standard deviation.
Model 0: unadjusted.
Model 1: adjusted for age, sex, ethnicity and admission sites, urban area, education level, annal household income.
Model 2: additionally adjusted for alcohol consumption, smoke status, high-fat diet, low fruit and vegetable intake, physical activity, second-hand smoking exposure, biomass fuel exposure, 3-year average temperature and 3-year average humidity.
The WQS logistic regression models showed that the WQS index of the mixed constituents was positively associated with MAFLD risk (OR 1.490, 95% CI 1.360- 1.632). In the pollutant-mixture, nitrate, sulfate, BC, OM, and ammonium weight estimations were 0.670, 0.192, 0.064, 0.038, and 0.036, respectively (Fig. 2).
Fig. 2.
Weight of each constituent in the association between PM2.5 joint exposure and MAFLD by weighted quantile sum regression.
Weighted quantile sum regression model was adjusted for age, sex, ethnicity and admission sites, urban area, education level, annal household income, alcohol consumption, smoke status, high-fat diet, low fruit and vegetable intake, physical activity, second-hand smoking exposure, biomass fuel exposure, 3-year average temperature and 3-year average humidity. BC, black carbon; MAFLD, metabolic dysfunction-related fatty liver disease; OM, organic matter; PM2.5, particulate matter 2.5 μm or less in diameter.
Subgroup analyses showed consistent positive associations of PM2.5 and its constituents with MAFLD across different subgroups (Fig. 3). Certain subgroups of people are more susceptible to PM2.5 and its constituents, including males, older adults (≥65 years-old), current smokers, and those who consume a high-fat diet. For example, the ORs of nitrate (1.506, 1.344-1.688), sulfate (1.897, 1.700-2.116), ammonium (1.794, 1.598-2.015), BC (1.632, 1.464-1.818) and OM (1.389, 1.242-1.555) were higher in males (Tables S2–S6).
Fig. 3.
Odds ratio (95% CIs) of MAFLD associated with each SD increase in 3-year exposure to PM2.5 and its five components stratified by demographic and lifestyle factors.
PM2.5, particulate matter 2.5 μm or less in diameter.
Sensitivity analyses further validated the reliability of the primary findings. After additionally adjusting for central obesity and diabetes mellitus, the OR of MAFLD associated with joint exposure to PM2.5 constituents was 1.780 (1.614–1.963) (Table S7). Sensitivity analyses suggested similar results of estimated ORs of MAFLD for PM2.5 and its constituents when changing the exposure-window to 2-year or 4-year concentrations (Table S8). Little change in results occurs when additionally excluding participants with self-reported pregnancy, cancer, or tuberculosis and those from Lhasa (Tables S9–S11). The ORs for PM2.5 and its constituents are slightly lower when additionally adjusted for a family history of hypertension and diabetes mellitus (Table S12). The concentration-response relationships of the 3-year average pollutant and MAFLD suggest that these relationships are approximately linear (Fig. S2). As for the association of PM2.5 constituents and the severity of MAFLD, we observed significant positive associations of most PM2.5 constituents with the severity of liver fibrosis (Table S13) and slightly positive (but not significant) associations with the number of metabolic disorders (Table S14). This lack of significance could be explained by the fact that fewer people had more severe metabolic disorders (Table S15), so the sample size was insufficient to explore this association.
Discussion
As previously mentioned, ambient PM2.5 is a mixture of various chemical constituents. Identifying the toxic agents in PM2.5 and quantifying each constituent’s effect on the health outcome of interest would be valuable.11 Although a few studies have reported the associations between PM2.5 mass and the risk of liver diseases,5,[21], [22], [23] it is unclear which constituent of PM2.5 contributes the most to MAFLD. Based on a large-scale multi-ethnic epidemiological survey in southwest China, this study of 80,201 individuals investigated the association between MAFLD and long-term exposure to PM2.5 chemical constituents (BC, OM, sulfate, nitrate, and ammonium).
We found that increased concentrations of nitrate, sulfate, and possibly BC, were associated with an increased risk of MAFLD using either the pollutant-specific or joint analyses strategies. Our findings were robust when adjusting for an extended set of covariates. Our findings suggested that males were more susceptible to associations between MAFLD and its major chemical constituents, and nitrate may play the most considerable role in increasing MAFLD risk. These robust findings contribute to the development of evidence-based clinical approaches for assessing ambient particulate pollution risk, identifying vulnerable individuals, and providing interventions.24,25
Given the paucity of studies on PM2.5 constituents and MAFLD, we interpret the results of this paper with reference to the available evidence on PM2.5 constituents and metabolic disorders or metabolic diseases.
Regarding PM2.5 mass, we estimated that each SD increase in PM2.5 may give rise to an OR of 1.480 (95% CI 1.366-1.605). This finding is broadly consistent with previous epidemiologic studies investigating the association of ambient PM2.5 with either MAFLD or NAFLD.[5], [6], [7],23 Besides, numerous studies have found positive associations between the mass concentrations of PM2.5 and increased incidences of metabolic disorders or diseases.[26], [27], [28], [29], [30] For example, a study of middle-aged and elderly Chinese adults found that an IQR increase in PM2.5 was related to higher odds of MetS (OR 1.39, 95% CI 1.11-1.75).13 Our findings are consistent with recent literature demonstrating an increased risk of metabolic disorders or diseases (including MAFLD) associated with long-term exposure to PM2.5.
The pollutant-specific analysis indicated that the five PM2.5 constituents were all positively associated with MAFLD, with sulfate having the highest effect (OR 1.618, 1.501–1.744). Further, the joint exposure analysis found that the effect of the five-constituent mixture is similar to PM2.5 mass, and nitrate (67.0%) contributed most to the association of MAFLD with the five-constituent mixture, followed by sulfate (19.2%). Our findings point to the need to better control the sources of particulate matter as targets for risk prevention. Typically, nitrate particles are formed by the oxidation of nitrogen oxides emitted from vehicles and other combustion sources;31 sulfate particles are formed by the oxidation of gaseous sulfur dioxide emitted from coal or oil burning; OM and BC may predominantly result from vehicle emissions, coal combustion, and biomass burning;32,33 and ammonium is related to the concentration of ammonia, which is dominated by agriculture activities.34 To our knowledge, this is the first epidemiologic study that evaluates the health effect of PM2.5 constituents on MAFLD and quantifies the relative contributions of these constituents.
Our epidemiologic findings are consistent with previous mechanistic evidence that linked ambient PM2.5 to the liver. Key biological mechanisms that explain the metabolic effects of PM2.5 on the liver include oxidative stress, inflammatory responses, and fibrosis.8,[35], [36], [37], [38] Human and animal studies have shown that PM2.5 exposure may alter the plasma lipidome and hepatic lipid metabolism,39,40 which further promotes systemic and hepatic inflammation.38 PM2.5 may also impair oxidative homeostasis and induce oxidative injury, further activating hepatic stellate cells.41 In addition, after long-term exposure, PM2.5 particles will accumulate in Kupffer cells and trigger inflammation and hepatic stellate cell collagen synthesis.42
Inorganic compounds, such as particulate sulfate, nitrate, and ammonium, make up a large fraction of ambient PM2.5. Nitrate and sulfate in particulate matter are mainly produced as a secondary aerosol by oxidizing sulfur dioxide (SO2) and nitrogen oxides (NOx). Two population-level studies separately found that exposure to sulfate could affect levels of IL1β, IL5, IL7, IL12, and IFN-γ and increase the risk of MetS, suggesting that sulfate affects systemic inflammation and metabolic diseases.13,43 However, evidence on nitrate and metabolic disorders or diseases is inconsistent. A study in children and adolescents found that nitrate may increase the risk of several metabolic disorders, including MetS, central obesity, and high blood pressure,44 but similar results were not observed in middle-aged and elderly adults.13 Previous epidemiologic studies on particulate ammonium and metabolic disorders or diseases are inconsistent.12,13 The underlying biological mechanisms by which inorganic particulate compounds affect metabolic health remain to be further explored by future studies.
As for carbon species, BC and OM were positively associated with MAFLD. Several epidemiologic studies have demonstrated associations between exposure to carbon species and metabolic diseases or other biomarkers. For instance, a longitudinal study found that exposure to BC was associated with increased risks of total cardiovascular disease and hypertension in Chinese adults.45 Also, organic carbon was positively associated with cytokines, including IL8 and MIP-1β, indicating that organic compounds may induce systemic inflammation.43
Generally stronger positive associations were also observed for all constituents in males, for most of the constituents in smokers, and for sulfate and ammonium in participants with a high-fat diet. Previous studies reported favorable gene expression in females in response to long-term exposure to air pollution, while sex hormone levels may be associated with differential effects of air pollution.46 In addition, smoking is generally considered a risk factor for metabolic diseases. Our findings indicate that smoking and PM2.5 and most of its constituents may have additional effects on the risk of MAFLD. A high-fat diet may lead to obesity, bringing higher metabolism-related risks. This study found that, in people on a high-fat diet, sulfate and ammonium were more strongly positively associated with MAFLD, similar to other studies’ findings. However, this study did not find statistically significant heterogeneity in the effect of sulfate and ammonium on the presence of central obesity and diabetes. More studies are required to validate the mechanisms underlying these associations.
No matter the concentration, ambient air pollution will threaten people’s health and bring a heavy disease burden to society, considering its ubiquitous existence and the large number of people affected. Therefore, interventions to reduce the harmful health impacts of PM2.5 and its constituents are critical. The findings of this study could help the government develop more targeted air pollution regulations, promote the development of individual precise protective equipment, and also inspire physicians to protect susceptible patients in MAFLD-related clinical practice.
This study benefits from the large-scale population sizes (76,727 participants included) of CMEC and the wide range of ambient PM2.5 concentrations in southwest China. The CMEC was conducted with well-established standard operating procedures and rigorous quality control measures, which were reported elsewhere.15,16 Also, the exposure data were simulated using the same method used in the assessment of ambient air pollution for the Global Burden of Disease study, which has been shown to have minor errors.17,47 Further strengths are the WQS method to evaluate the association of joint exposure to PM2.5 constituents with MAFLD. WQS can estimate the weights of each constituent and their joint effect simultaneously; thus, it gives easy-to-understand results to guide the control of the most harmful particulate constituents. Evidence on the positive associations of PM2.5 and its constituents with liver fibrosis indices and MAFLD phenotypes also strengthened this work.
Nevertheless, we also acknowledge several limitations. First, there may be some risk of exposure misclassification because pollution exposures were matched to the participant’s most recent residential address without considering individual mobility. In addition, as a cross-sectional study, our study evaluated pollution exposures during a prespecified period of 3 years before baseline enrollment but did not allow us to examine associations with the progression of MAFLD. Longitudinal analyses using MAFLD measurements from follow-up surveys will provide better evidence of the relationship between long-term exposure to PM2.5 constituents and MAFLD. Last, future work should consider the source apportion of PM2.5 constituents to provide stricter regulation of the human sources of emissions that form these constituents.
To our knowledge, this study is the first large-scale epidemiologic study exploring the associations between PM2.5 constituents and MAFLD. We observed positive associations between a mixture of PM2.5 chemical constituents and MAFLD and quantified specific weights of individual chemical constituents on MAFLD using WQS regression methods. This research indicates that particulate nitrate and sulfate of PM2.5 play major harmful roles on MAFLD and thus should be paid more attention. Moves to mitigate these ambient chemical constituents might bring greater benefits to public health. This study also suggests that males and smokers were more susceptible to the association between PM2.5 constituents and MAFLD.
Financial support
This work was supported by the National Natural Science Foundation of China (Grant No. 82103943, 82073667, and 81973151), and the National Key Research and Development Program of China (Grant No. 2017YFC0907305).
Authors’ contributions
Yin J. and Zhao X. served as co-senior authors. Concept and design: Guo B., Huang S., Li S., and Zhao X. Acquisition of data: Zhao X., Yin J., Lin H., Li Y., Qin Z., Jiang X., Wang Z., Pan Y., Li S., and Guo B. Analysis or interpretation of data: Guo B., Huang S., Li S., Han X., Lin H., and Zhao X. Drafting of the manuscript: Guo B., Huang S., and Li S. Critical revision of the manuscript for important intellectual content: Guo B., Huang S., Zhang J., and Zhao X. Statistical analysis: Huang S. and Guo B. Obtained funding: Guo B., Zhao X., and Zhang J. Administrative, technical, or material support: Guo B., Huang S., Han X., Lin H., Li Y., Qin Z., Jiang X., and Wang Z. Supervision: Zhao X., Yin J., and Zhang J.
Data availability statement
The data supporting this study's findings are available from the corresponding author upon reasonable request.
Conflict of interest
No potential conflicts of interest relevant to this article were reported.
Please refer to the accompanying ICMJE disclosure forms for further details.
Acknowledgments
The authors are grateful to all participating respondents, practitioners, and researchers of the China Multi-Ethnic Cohort (CMEC) study. The authors further acknowledge Professor Xiaosong Li of the West China School of Public Health, Sichuan University, for his exceptional leadership and pioneering contributions to the establishment of CMEC. Unfortunately, Prof. Li passed away in 2019 and will be remembered forever.
Footnotes
Author names in bold designate shared co-first authorship
Supplementary data to this article can be found online at https://doi.org/10.1016/j.jhepr.2023.100912.
Contributor Information
Jianzhong Yin, Email: yinjianzhong2005@sina.com.
Xing Zhao, Email: xingzhao@scu.edu.cn.
Supplementary data
The following are the supplementary data to this article:
References
- 1.Lim G.E.H., Tang A., Ng C.H., Chin Y.H., Lim W.H., Tan D.J.H., et al. An observational data meta-analysis on the differences in prevalence and risk factors between mafld vs nafld. Clin Gastroenterol Hepatol. 2023;21(3):619–629.e7. doi: 10.1016/j.cgh.2021.11.038. [DOI] [PubMed] [Google Scholar]
- 2.Chan K.E., Koh T.J.L., Tang A.S.P., Quek J., Yong J.N., Tay P., et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107(9):2691–2700. doi: 10.1210/clinem/dgac321. [DOI] [PubMed] [Google Scholar]
- 3.Younossi Z., Anstee Q.M., Marietti M., Hardy T., Henry L., Eslam M., et al. Global burden of nafld and nash: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi: 10.1038/nrgastro.2017.109. [DOI] [PubMed] [Google Scholar]
- 4.Lazarus J.V., Mark H.E., Anstee Q.M., Arab J.P., Batterham R.L., Castera L., et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19(1):60–78. doi: 10.1038/s41575-021-00523-4. [DOI] [PubMed] [Google Scholar]
- 5.Guo B., Guo Y., Nima Q., Feng Y., Wang Z., Lu R., et al. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. J Hepatol. 2022;76(3):518–525. doi: 10.1016/j.jhep.2021.10.016. [DOI] [PubMed] [Google Scholar]
- 6.Sun S., Yang Q., Zhou Q., Cao W., Yu S., Zhan S., et al. Long-term exposure to fine particulate matter and non-alcoholic fatty liver disease: a prospective cohort study. Gut. 2022;71(2):443–445. doi: 10.1136/gutjnl-2021-324364. [DOI] [PubMed] [Google Scholar]
- 7.Li F.R., Liao J., Zhu B., Li X., Cheng Z., Jin C., et al. Long-term exposure to air pollution and incident non-alcoholic fatty liver disease and cirrhosis: a cohort study. Liver Int. 2022 doi: 10.1111/liv.15416. [DOI] [PubMed] [Google Scholar]
- 8.Zheng Z., Zhang X., Wang J., Dandekar A., Kim H., Qiu Y., et al. Exposure to fine airborne particulate matters induces hepatic fibrosis in murine models. J Hepatol. 2015;63(6):1397–1404. doi: 10.1016/j.jhep.2015.07.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Xu M.X., Ge C.X., Qin Y.T., Gu T.T., Lou D.S., Li Q., et al. Prolonged pm2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia. Free Radic Biol Med. 2019;130:542–556. doi: 10.1016/j.freeradbiomed.2018.11.016. [DOI] [PubMed] [Google Scholar]
- 10.Colombo M., Barouki R. Expanding the liver exposome: should hepatologists care about air pollution? J Hepatol. 2022;76(3):495–497. doi: 10.1016/j.jhep.2021.11.001. [DOI] [PubMed] [Google Scholar]
- 11.Cassee F.R., Heroux M.E., Gerlofs-Nijland M.E., Kelly F.J. Particulate matter beyond mass: recent health evidence on the role of fractions, chemical constituents and sources of emission. Inhal Toxicol. 2013;25(14):802–812. doi: 10.3109/08958378.2013.850127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Zhou P., Mo S., Peng M., Yang Z., Wang F., Hu K., et al. Long-term exposure to pm(2.5) constituents in relation to glucose levels and diabetes in middle-aged and older Chinese. Ecotoxicol Environ Saf. 2022;245:114096. doi: 10.1016/j.ecoenv.2022.114096. [DOI] [PubMed] [Google Scholar]
- 13.Yi W., Zhao F., Pan R., Zhang Y., Xu Z., Song J., et al. Associations of fine particulate matter constituents with metabolic syndrome and the mediating role of apolipoprotein B: a multicenter study in middle-aged and elderly Chinese adults. Environ Sci Technol. 2022;56(14):10161–10171. doi: 10.1021/acs.est.1c08448. [DOI] [PubMed] [Google Scholar]
- 14.Kim S.Y., Sheppard L., Kaufman J.D., Bergen S., Szpiro A.A., Larson T.V., et al. Individual-level concentrations of fine particulate matter chemical components and subclinical atherosclerosis: a cross-sectional analysis based on 2 advanced exposure prediction models in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2014;180(7):718–728. doi: 10.1093/aje/kwu186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zhao X., Hong F., Yin J., Tang W., Zhang G., Liang X., et al. Cohort profile: the China multi-ethnic cohort (cmec) study. Int J Epidemiol. 2021;50(3) doi: 10.1093/ije/dyaa185. 721–721l. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sun C., Guo B., Liu X., Xiao X., Zhao X. Interviewer error within the face-to-face food frequency questionnaire in large multisite epidemiologic studies. Am J Epidemiol. 2022;191(5):921–929. doi: 10.1093/aje/kwac024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.van Donkelaar A., Martin R.V., Li C., Burnett R.T. Regional estimates of chemical composition of fine particulate matter using a combined geoscience-statistical method with information from satellites, models, and monitors. Environ Sci Technol. 2019;53(5):2595–2611. doi: 10.1021/acs.est.8b06392. [DOI] [PubMed] [Google Scholar]
- 18.Eslam M., Newsome P.N., Sarin S.K., Anstee Q.M., Targher G., Romero-Gomez M., et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi: 10.1016/j.jhep.2020.03.039. [DOI] [PubMed] [Google Scholar]
- 19.Carrico C., Gennings C., Wheeler D.C., Factor-Litvak P. Characterization of weighted quantile sum regression for highly correlated data in a risk analysis setting. J Agric Biol Environ Stat. 2015;20(1):100–120. doi: 10.1007/s13253-014-0180-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., et al. The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–577. doi: 10.7326/0003-4819-147-8-200710160-00010. [DOI] [PubMed] [Google Scholar]
- 21.Pan W.C., Wu C.D., Chen M.J., Huang Y.T., Chen C.J., Su H.J., et al. Fine particle pollution, alanine transaminase, and liver cancer: a Taiwanese prospective cohort study (reveal-hbv) J Natl Cancer Inst. 2016;108(3) doi: 10.1093/jnci/djv341. [DOI] [PubMed] [Google Scholar]
- 22.Li Y., Yuan X., Wei J., Sun Y., Ni W., Zhang H., et al. Long-term exposure to ambient air pollution and serum liver enzymes in older adults: a population-based longitudinal study. Ann Epidemiol. 2022 doi: 10.1016/j.annepidem.2022.05.011. [DOI] [PubMed] [Google Scholar]
- 23.VoPham T., Kim N.J., Berry K., Mendoza J.A., Kaufman J.D., Ioannou G.N. Pm(2.5) air pollution exposure and nonalcoholic fatty liver disease in the nationwide inpatient sample. Environ Res. 2022;213:113611. doi: 10.1016/j.envres.2022.113611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hadley M.B., Baumgartner J., Vedanthan R. Developing a clinical approach to air pollution and cardiovascular health. Circulation. 2018;137(7):725–742. doi: 10.1161/CIRCULATIONAHA.117.030377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Schraufnagel D.E., Balmes J.R., Cowl C.T., De Matteis S., Jung S.H., Mortimer K., et al. Air pollution and noncommunicable diseases: a review by the forum of international respiratory societies' environmental committee, part 2: air pollution and organ systems. Chest. 2019;155(2):417–426. doi: 10.1016/j.chest.2018.10.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Eze I.C., Hemkens L.G., Bucher H.C., Hoffmann B., Schindler C., Künzli N., et al. Association between ambient air pollution and diabetes mellitus in europe and north america: systematic review and meta-analysis. Environ Health Perspect. 2015;123(5):381–389. doi: 10.1289/ehp.1307823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chen Z., Salam M.T., Toledo-Corral C., Watanabe R.M., Xiang A.H., Buchanan T.A., et al. Ambient air pollutants have adverse effects on insulin and glucose homeostasis in mexican americans. Diabetes Care. 2016;39(4):547–554. doi: 10.2337/dc15-1795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Dai L., Koutrakis P., Coull B.A., Sparrow D., Vokonas P.S., Schwartz J.D. Use of the adaptive lasso method to identify pm2.5 components associated with blood pressure in elderly men: the veterans affairs normative aging study. Environ Health Perspect. 2016;124(1):120–125. doi: 10.1289/ehp.1409021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Munzel T., Gori T., Al-Kindi S., Deanfield J., Lelieveld J., Daiber A., et al. Effects of gaseous and solid constituents of air pollution on endothelial function. Eur Heart J. 2018;39(38):3543–3550. doi: 10.1093/eurheartj/ehy481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Guo Q., Zhao Y., Xue T., Zhang J., Duan X. Association of pm(2.5) and its chemical compositions with metabolic syndrome: a nationwide study in middle-aged and older Chinese adults. Int J Environ Res Public Health. 2022;19(22) doi: 10.3390/ijerph192214671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zhai S., Jacob D.J., Wang X., Liu Z., Wen T., Shah V., et al. Control of particulate nitrate air pollution in China. Nat Geosci. 2021;14(6):389–395. doi: 10.1038/s41561-021-00726-z. [DOI] [Google Scholar]
- 32.Zhou J., Xiong Y., Xing Z., Deng J., Du K. Characterizing and sourcing ambient pm2.5 over key emission regions in China ii: organic molecular markers and cmb modeling. Atmos Environ. 2017;163:57–64. doi: 10.1016/j.atmosenv.2017.05.033. [DOI] [Google Scholar]
- 33.Huang Y., Wang L., Cheng X., Wang J., Li T., He M., et al. Characteristics of particulate matter at different pollution levels in chengdu, southwest of China. Atmosphere. 2021;12(8) doi: 10.3390/atmos12080990. [DOI] [Google Scholar]
- 34.Jiang B., Xia D. Ammonia control represents the key for pm2.5 elimination: insights for global air pollution control interconnected from pm2.5 events in China. Clean Technol Environ Policy. 2020;23(3):829–841. doi: 10.1007/s10098-020-01923-x. [DOI] [Google Scholar]
- 35.Munzel T., Sorensen M., Gori T., Schmidt F.P., Rao X., Brook F.R., et al. Environmental stressors and cardio-metabolic disease: part II-mechanistic insights. Eur Heart J. 2017;38(8):557–564. doi: 10.1093/eurheartj/ehw294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rajagopalan S., Brook R.D. Air pollution and type 2 diabetes: mechanistic insights. Diabetes. 2012;61(12):3037–3045. doi: 10.2337/db12-0190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Chen H., Oliver B.G., Pant A., Olivera A., Poronnik P., Pollock C.A., et al. Effects of air pollution on human health – mechanistic evidence suggested by in vitro and in vivo modelling. Environ Res. 2022;212(Pt C):113378. doi: 10.1016/j.envres.2022.113378. [DOI] [PubMed] [Google Scholar]
- 38.Zheng Z., Xu X., Zhang X., Wang A., Zhang C., Hüttemann M., et al. Exposure to ambient particulate matter induces a nash-like phenotype and impairs hepatic glucose metabolism in an animal model. J Hepatol. 2013;58(1):148–154. doi: 10.1016/j.jhep.2012.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yang S., Chen R., Zhang L., Sun Q., Li R., Gu W., et al. Lipid metabolic adaption to long-term ambient pm(2.5) exposure in mice. Environ Pollut. 2021;269:116193. doi: 10.1016/j.envpol.2020.116193. [DOI] [PubMed] [Google Scholar]
- 40.Wang L., Chen G., Pan Y., Xia J., Chen L., Zhang X., et al. Association of long-term exposure to ambient air pollutants with blood lipids in Chinese adults: the China multi-ethnic cohort study. Environ Res. 2021;197:111174. doi: 10.1016/j.envres.2021.111174. [DOI] [PubMed] [Google Scholar]
- 41.Lin L., Qiu W., Luo Y., Lin S., Sun X., Chen W., et al. Oleanolic acid-loaded nanoparticles attenuate activation of hepatic stellate cells via suppressing tgf-beta1 and oxidative stress in pm2.5-exposed hepatocytes. Toxicol Appl Pharmacol. 2022;437:115891. doi: 10.1016/j.taap.2022.115891. [DOI] [PubMed] [Google Scholar]
- 42.Tan H.-H., Fiel M.I., Sun Q., Guo J., Gordon R.E., Chen L.C., et al. Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol. 2009;6(4):266–275. doi: 10.3109/15476910903241704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Han B., Xu J., Zhang Y., Li P., Li K., Zhang N., et al. Associations of exposure to fine particulate matter mass and constituents with systemic inflammation: a cross-sectional study of urban older adults in China. Environ Sci Technol. 2022;56(11):7244–7255. doi: 10.1021/acs.est.1c04488. [DOI] [PubMed] [Google Scholar]
- 44.Li J., Song Y., Shi L., Jiang J., Wan X., Wang Y., et al. Long-term effects of ambient pm2.5 constituents on metabolic syndrome in Chinese children and adolescents. Environ Res. 2023;220 doi: 10.1016/j.envres.2023.115238. [DOI] [PubMed] [Google Scholar]
- 45.Liu L., Zhang Y., Yang Z., Luo S., Zhang Y. Long-term exposure to fine particulate constituents and cardiovascular diseases in Chinese adults. J Hazard Mater. 2021;416:126051. doi: 10.1016/j.jhazmat.2021.126051. [DOI] [PubMed] [Google Scholar]
- 46.Vrijens K., Winckelmans E., Tsamou M., Baeyens W., De Boever P., Jennen D., et al. Sex-specific associations between particulate matter exposure and gene expression in independent discovery and validation cohorts of middle-aged men and women. Environ Health Perspect. 2017;125(4):660–669. doi: 10.1289/EHP370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Brauer M., Freedman G., Frostad J., van Donkelaar A., Martin R.V., Dentener F., et al. Ambient air pollution exposure estimation for the global burden of disease 2013. Environ Sci Technol. 2016;50(1):79–88. doi: 10.1021/acs.est.5b03709. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data supporting this study's findings are available from the corresponding author upon reasonable request.




